Clinical effects of Lingguizhugan decoction in the treatment of hypertension: a systematic review and meta-analysis

被引:5
作者
Xie, Pingchang [1 ]
Li, Xinmei [2 ]
Jiang, Hua [2 ]
Qiu, Sijie [2 ]
Liang, Yunyu [2 ]
机构
[1] Guangdong Prov Hosp Tradit Chinese Med, Emergency Dept, Guangdong Prov Key Lab Res Emergency TCM, Guangzhou, Peoples R China
[2] Guangdong Prov Hosp Tradit Chinese Med, Dept Geriatr, Guangzhou 510000, Peoples R China
关键词
Lingguizhugan decoction; hypertension; western medicine; meta-analysis; TRADITIONAL CHINESE MEDICINE;
D O I
10.21037/apm-21-2639
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Lingguizhugan decoction is commonly used to treat metabolic syndrome; however, its curative effect on hypertension is still unclear. Our study aimed to evaluate the clinical efficacy and safety of Lingguizhugan decoction combined with western medicine in the treatment of hypertension. Methods: We searched 7 electronic databases for relevant studies and full-text articles involved in the evaluation of clinical effects difference between Lingguizhugan decoction combined with western medicine and western medicine alone. All included articles were quality assessed and data analysis was conducted with Review Manager (5.4). Sensitivity analysis was performed, and the results were visualized by means of forest and funnel plots. Results were expressed as risk ratio (RR) or mean difference (MD), together with their 95% confidence intervals (CIs). Results: In total, 7 studies eventually met our inclusion criteria. The results showed that Lingguizhugan decoction combined with western medicine had a better improvement in decrease systolic blood pressure (SBP) (MD=12.33 mmHg; 95% CI: 3.37 to 21.28; P=0.007) and diastolic blood pressure (DBP) (MD =7.42 mmHg; 95% CI: 1.89 to 12.95; P=0.009) than western medicine alone, it also had a higher effective ratio (RR=1.20; 95% CI: 1.11 to 1.31; P<0.0001) and lower adverse reactions (RR=0.51; 95% CI: 0.30 to 0.86; P=0.01). The results were robust and no obvious publication bias was observed in this study. Discussion: Our research supported that Lingguizhugan decoction combined with western medicine can effectively reduce patients' blood pressure and improve their clinical symptoms. Because of the limitation in the quantity and quality of the included studies, further large sample and multi center follow-up controlled trials should be carried out to validate our conclusions.
引用
收藏
页码:11529 / 11538
页数:10
相关论文
共 39 条
  • [1] Advances and challenges in cirrhosis and portal hypertension
    Berzigotti, Annalisa
    [J]. BMC MEDICINE, 2017, 15
  • [2] Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response
    Beswick, RA
    Zhang, HF
    Marable, D
    Catravas, JD
    Hill, WD
    Webb, RC
    [J]. HYPERTENSION, 2001, 37 (02) : 781 - 786
  • [3] Effects of the Modified Linggui Zhugan Decoction ((sic)) Combined with Short-term Very Low Calorie Diets on Glycemic Control in Newly Diagnosed Type 2 Diabetics
    Chen Ding-sheng
    Ke Bin
    Huang Ying-juan
    Meng Jun
    Zhang Jun-jie
    Chen Ze-xiong
    Michalsen Andreas
    Qin Jian
    [J]. JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2011, 31 (03) : 185 - 188
  • [4] Chobanian AV, 2017, MED CLIN N AM, V101, P219, DOI [10.1016/j.mcna.2016.08.016, 10.5603/AH.2015.0020]
  • [6] Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
    Esler, Murray D.
    Krum, Henry
    Sobotka, Paul A.
    Schlaich, Markus P.
    Schmieder, Roland E.
    Boehm, Michael
    Mahfoud, Felix
    Sievert, Horst
    Wunderlich, Nina
    Rump, Lars Christian
    Vonend, Oliver
    Uder, Michael
    Lobo, Mel
    Caulfield, Mark
    Erglis, Andrejs
    Azizi, Michel
    Sapoval, Marc
    Thambar, Suku
    Persu, Alexandre
    Renkin, Jean
    Schunkert, Heribert
    Weil, Joachim
    Hoppe, Uta C.
    Walton, Tony
    Scheinert, Dierk
    Binder, Thomas
    Januszewicz, Andrzej
    Witkowski, Adam
    Ruilope, Luis M.
    Whitbourn, Robert
    Bruck, Heike
    Downes, Mark
    Luescher, Thomas F.
    Jardine, Alan G.
    Webster, Mark W.
    Zeller, Thomas
    Sadowski, Jerzy
    Bartus, Krzysztof
    Straley, Craig A.
    Barman, Neil C.
    Lee, David P.
    Witteles, Ronald M.
    Bhalla, Vivek
    Massaro, Joseph M.
    [J]. LANCET, 2010, 376 (9756) : 1903 - 1909
  • [7] Fang HY, 2010, J ANHUI TRADITIONAL, V12, P322
  • [8] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Gomez Sanchez, Miguel Angel
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (01) : 67 - +
  • [9] Effect of Lingguizhugan decoction on myocardial Nuclear factor kappa B protein expression in rats with chronic heart failure
    Huang, Jinling
    Wang, Liang
    Shi, Hui
    Hou, Xiaoyan
    [J]. JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2013, 33 (03) : 343 - 348
  • [10] Huang Shuai, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P1007